Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance
Helicobacter pylori (H.pylori) is a vehicles common gastrointestinal bacterial strain closely associated with the incidence of chronic gastritis, peptic ulcers, gastric mucosa-associated lymphoid tissue lymphoma, and gastric cancer.A current research and clinical challenge is the increased rate of antibiotic resistance in H.pylori, which has led to